每年專案
個人檔案
學歷
- 2014-2020 臺北醫學大學轉譯醫學博士學位學程博士
- 2000-2007 臺北醫學大學醫學系學士
經歷
- 臺北醫學大學附設醫院專任主治醫師
- 2021.01- 臺北醫學大學附設醫院放射腫瘤科主任
- 2020.11- 臺北醫學大學醫學系放射線學科助理教授
- 2019.08-2020.12 臺北醫學大學附設醫院放射腫瘤科代主任
- 2014.04-2015.06 臺北醫學大學附設醫院兼任主治醫師
- 2013.04-2014.09 壢新醫院兼任主治醫師
- 2012.11-2015.06 臺北市立萬芳醫院專任主治醫師
指紋
- 12 類似的個人檔案
網路
專案
- 2 已完成
研究成果
- 25 引文
- 3 h-指數
- 11 文章
-
A combined systemic strategy for overcoming cisplatin resistance in head and neck cancer: From target identification to drug discovery
Chen, Y. J., You, G. R., Lai, M. Y., Lu, L. S., Chen, C. Y., Ting, L. L., Lee, H. L., Kanno, Y., Chiou, J. F. & Cheng, A. J., 十一月 2020, 於: Cancers. 12, 11, p. 1-20 20 p., 3482.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Ex vivo expansion and drug sensitivity profiling of circulating tumor cells from patients with small cell lung cancer
Lee, H. L., Chiou, J. F., Wang, P. Y., Lu, L. S., Shen, C. N., Hsu, H. L., Burnouf, T., Ting, L. L., Chou, P. C., Chung, C. L., Lee, K. L., Shiah, H. S., Liu, Y. L. & Chen, Y. J., 十一月 2020, 於: Cancers. 12, 11, p. 1-17 17 p., 3394.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Molecular-clinical correlation in pediatric medulloblastoma: A cohort series study of 52 cases in Taiwan
Wu, K. S., Ho, D. M. T., Jou, S. T., Yu, A. L., Tran, H. M., Liang, M. L., Chen, H. H., Lee, Y. Y., Chen, Y. W., Lin, S. C., Chang, F. C., Tsai, M. L., Liu, Y. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Sung, S. Y., Chang, C. C., Changou, C. A., Liang, K. H. 及其他7, , 三月 2020, 於: Cancers. 12, 3, 653.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Upregulation of protein synthesis and proteasome degradation confers sensitivity to proteasome inhibitor bortezomib in myc-atypical teratoid/rhabdoid tumors
Tran, H. M., Wu, K. S., Sung, S. Y., Changou, C. A., Hsieh, T. H., Liu, Y. R., Liu, Y. L., Tsai, M. L., Lee, H. L., Hsieh, K. L. C., Huang, W. C., Liang, M. L., Chen, H. H., Lee, Y. Y., Lin, S. C., Ho, D. M. T., Chang, F. C., Chao, M. E., Chen, W., Chu, S. S. 及其他4, , 三月 22 2020, 於: Cancers. 12, 3, 752.研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取 -
Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolization
Lee, H. L., Tsai, J. T., Chen, C. Y., Lin, Y. C., Ho, C. B., Ting, L. L., Kuo, C. C., Lai, I. C., Lin, C. Y., Tang, J. H., Huang, Y. M., Kao, W. Y., Cheng, S. W., Shen, C. N., Chen, S. W. & Chiou, J. F., 一月 1 2019, 於: Therapeutic Advances in Medical Oncology. 11研究成果: 雜誌貢獻 › 文章 › 同行評審
開啟存取
資料集
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://figshare.com/collections/Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/3931717/1
資料集: Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606626/1
資料集: Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM3_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606698/1
資料集: Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Contributor), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Contributor), Bai, K. (Contributor) & Yao, C. (Contributor), Unknown Publisher, 十一月 15 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://springernature.figshare.com/articles/journal_contribution/MOESM2_of_Active_fraction_HS7_from_Taiwanofungus_camphoratus_inhibits_AKT-mTOR_ERK_and_STAT3_pathways_and_induces_CDK_inhibitors_in_CL1-0_human_lung_cancer_cells/5606662/1
資料集: Dataset